These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6994764)

  • 1. Acute action of guanfacine on peripheral circulation in hypertensive patients: measurements of arterial flow of the calf and of the forefoot, of venous capacity of the calf, of the blood pressure and of the heart rate.
    Ehringer H; Berger G; Ingerle H; Konecny U; Wöss A
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):115S-121S. PubMed ID: 6994764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemodynamics in hypertensive patients before and during guanfacine treatment.
    Schäfer N; Rauh J; Rosenthal J
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):133S-135S. PubMed ID: 6994767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the vasodilator endralazine given with the antihypertensive agent guanfacine on heart rate and blood pressure of spontaneously hypertensive rats and normotensive dogs.
    Salzmann R; Gerber W; Pally C; Scholtysik G
    J Pharm Pharmacol; 1983 May; 35(5):293-8. PubMed ID: 6134797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guanfacine in essential hypertension: effect on blood pressure, plasma noradrenaline concentration and plasma renin activity.
    Schoeppe W; Brecht HM
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):97S-101S. PubMed ID: 6994788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of guanfacine on blood pressure and renin activity in hypertensive patients.
    Rosenthal J
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):91S-96S. PubMed ID: 6994787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of guanfacine on vigilance.
    Heidbreder E; Pagel G; Roeckel A; Heidland A
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):169S-172S. PubMed ID: 6994772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of guanfacine.
    Scholtysik G
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):21S-24S. PubMed ID: 6249333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic and endocrine responses to guanfacine in normotensive volunteers and hypertensive patients.
    Rosenthal JH
    Am J Cardiol; 1986 Mar; 57(9):22E-26E. PubMed ID: 3513526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and chronic renal effects of guanfacine in essential and renal hypertension.
    Roeckel A; Heidland A
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):141S-149S. PubMed ID: 6994769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure, heart rate, catecholamines and plasma renin activity following institution and withdrawal of guanfacine treatment in moderate hypertension.
    Manhem P; Hökfelt B
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):109S-114S. PubMed ID: 6994763
    [No Abstract]   [Full Text] [Related]  

  • 11. Peripheral effects of guanfacine compared to those of clonidine in the dog.
    Hashimoto K; Nakagawa Y; Hashimoto T; Tsukada T; Takeda K; Imai S
    Jpn Circ J; 1980 Nov; 44(11):883-92. PubMed ID: 6253699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antihypertensive effect of guanfacine in rats].
    Nakagawa Y; Takeda K; Hashimoto T; Sakurai H; Mitomi A; Imai S; Hamamura M; Kumada M
    Nihon Yakurigaku Zasshi; 1981 Mar; 77(3):295-312. PubMed ID: 6762984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guanfacine and clonidine: antihypertensive and withdrawal characteristics after continuous infusion and its interruption in the spontaneously hypertensive and normotensive rat.
    Thoolen MJ; Timmermans PB; van Zwieten PA
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Apr; 319(1):82-6. PubMed ID: 7050735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal pharmacology of guanfacine.
    Scholtysik G
    Am J Cardiol; 1986 Mar; 57(9):13E-17E. PubMed ID: 3006469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of the hypotensive effect of guanfacine.
    Magometschnigg D; Bonelli J; Gassner A; Hitzenberger G; Lenzhofer R; Kleinberger G; Pall H
    Int J Clin Pharmacol Ther Toxicol; 1982 Apr; 20(4):174-8. PubMed ID: 7042594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamic effects of guanfacine.
    Magometschnigg D; Hitzenberger G; Bonelli J
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):125S-131S. PubMed ID: 6994766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 8-OH-DPAT, flesinoxan and guanfacine: systemic and regional haemodynamic effects of centrally acting antihypertensive agents in anaesthetized rabbits.
    Hof RP; Fozard JR
    Br J Pharmacol; 1989 Apr; 96(4):864-71. PubMed ID: 2568144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of effects of guanfacine and clonidine on blood pressure, heart rate, urinary catecholamines, and cyclic nucleotides during and after administration to patients with mild to moderate hypertension.
    Nami R; Bianchini C; Fiorella G; Chierichetti SM; Gennari C
    J Cardiovasc Pharmacol; 1983; 5(4):546-51. PubMed ID: 6193349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Central hypotensive effects of guanfacine in anaesthetised rabbits (author's transl)].
    Ohkubo K; Suzuki K; Oguma M; Otorii T
    Nihon Yakurigaku Zasshi; 1982 Apr; 79(4):263-74. PubMed ID: 7047324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An ambulatory trial of guanfacine.
    Mann S; Millar Craig MW; Melville DI; Cashman PM; Raftery EB
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):103S-107S. PubMed ID: 6994762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.